Thursday, 6 December 2012
09:00 - 10:30
Postgraduate Course 1: ANAPHYLAXIS TRACK - Evaluation, Management and Prevention of Anaphylaxis
G.01 (HICC)
09:00 - 09:05
Welcoming Remarks
09:05 - 09:20
09:20 - 09:35
09:35 - 09:50
09:50 - 10:30
Discussion
|
Postgraduate Course 2: ASTHMA AND LOWER AIRWAY DISEASE TRACK - Biomarkers, Lung Function and Bronchial Provocation Tests of Asthma
G.02 (HICC)
09:00 - 09:05
Welcoming Remarks
09:05 - 09:20
09:20 - 09:35
2-2PG:
Assessing Lung Function |
09:35 - 09:50
2-3PG:
Bronchial Provocation |
09:50 - 10:30
Discussion
|
Postgraduate Course 3: DRUG ALLERGY TRACK - Practical Approaches to Aspirin and NSAID Hypersensitivity
G.03 (HICC)
09:00 - 09:05
Welcoming Remarks
09:05 - 09:20
09:20 - 09:35
3-2PG:
Diagnostic Testing |
09:35 - 09:50
3-3PG:
Prevention and Management |
09:50 - 10:30
Discussion
|
Postgraduate Course 4: UPPER AIRWAY ALLERGIES TRACK - Objective Assessment of Upper Airway Diseases: Hands-on Rhinolaryngoscopy and Nasal Challenge Tests
G.04 (HICC)
09:00 - 09:05
Welcoming Remarks
09:05 - 09:20
4-1PG:
Nasal Challenge Testing |
09:20 - 09:35
4-2PG:
Imaging |
09:35 - 09:50
4-3PG:
Nasal Endoscopy: Practical Aspects |
09:50 - 10:30
Discussion
|
Postgraduate Course 5: FOOD ALLERGY TRACK - Food Allergy Over the Life Course: From Childhood to Adulthood
G.05 (HICC)
09:00 - 09:05
Welcoming Remarks
09:05 - 09:20
09:20 - 09:35
09:35 - 09:50
09:50 - 10:30
Discussion
|
Postgraduate Course 6: IMMUNOTHERAPY TRACK - Allergy Testing In-Vivo and In-Vitro
G.06 (HICC)
09:00 - 09:05
Welcoming Remarks
09:05 - 09:20
6-1PG:
Interpretation of In-Vitro |
09:20 - 09:35
6-2PG:
Interpretation of In-Vivo |
09:35 - 09:50
09:50 - 10:30
Discussion
|
11:00 - 12:30
Postgraduate Course 7: ANAPHYLAXIS TRACK - Causes of Anaphylaxis
G.01 (HICC)
11:00 - 11:05
Welcoming Remarks
11:05 - 11:20
11:20 - 11:35
11:35 - 11:50
7-3PG:
Anaphylaxis in Vulnerable Patients |
11:50 - 12:30
Discussion
|
Postgraduate Course 8: ASTHMA AND LOWER AIRWAY DISEASE TRACK - Improving Patient’s Asthma Control and Quality of Life
G.02 (HICC)
11:00 - 11:05
Welcoming Remarks
11:05 - 11:20
8-1PG:
Compliance and Treatment Adherence |
11:20 - 11:35
8-2PG:
Improving Patient’s Quality of Life |
11:35 - 11:50
11:50 - 12:30
Discussion
|
Postgraduate Course 9: DRUG ALLERGY TRACK - Drug Allergy Evaluation and Management of Beta Lactam Allergy
G.03 (HICC)
11:00 - 11:05
Welcoming Remarks
11:05 - 11:20
9-1PG:
Patterns of Cross Reactivity |
11:20 - 11:35
9-2PG:
Clinical Presentation and Diagnosis |
11:35 - 11:50
9-3PG:
Desensitization Protocols |
11:50 - 12:30
Discussion
|
Postgraduate Course 10: UPPER AIRWAY ALLERGIES TRACK - Practical Aspects of Managing Upper Airway Allergies
G.04 (HICC)
11:00 - 11:05
Welcoming Remarks
11:05 - 11:20
11:20 - 11:35
10-2PG:
Managing Rhinosinusitis in Children |
11:35 - 11:50
11:50 - 12:30
Discussion
|
Postgraduate Course 11: FOOD ALLERGY TRACK - Food Allergy: Other Forms of Food Allergy
G.05 (HICC)
11:00 - 11:05
Welcoming Remarks
11:05 - 11:20
11-1PG:
Eosinophilic Esophagitis Update |
11:20 - 11:35
11-2PG:
Eosinophilic Gastroentrocolitis |
11:35 - 11:50
11-3PG:
Other Non- IgE Mediated Food Allergies |
11:50 - 12:30
Discussion
|
Postgraduate Course 12: IMMUNOTHERAPY TRACK - Practical Aspects of Immunotherapy
G.06 (HICC)
11:00 - 11:05
Welcoming Remarks
11:05 - 11:20
12-1PG:
Nuts and Bolts of Allergy Skin Testing |
11:20 - 11:35
11:35 - 11:50
11:50 - 12:30
Discussion
|
13:30 - 15:00
Postgraduate Course 13: ALLERGY, ASTHMA AND SLEEP DISORDERS TRACK - Gastroesophageal Reflux Disease (GERD)
G.01 (HICC)
13:30 - 13:35
Welcoming Remarks
13:35 - 13:50
13-1PG:
Clinical Signs and Symptoms |
13:50 - 14:05
13-2PG:
Clinical and Laboratory Diagnosis |
14:05 - 14:20
14:20 - 15:00
Discussion
|
Postgraduate Course 14: ASTHMA AND LOWER AIRWAY DISEASE TRACK - Asthma Exacerbations: Treatment and Prevention
G.02 (HICC)
13:30 - 13:35
Welcoming Remarks
13:35 - 13:50
13:50 - 14:05
14-2PG:
Acute Management and Prevention |
14:05 - 14:20
14:20 - 15:00
Discussion
|
Postgraduate Course 15: ATOPIC DERMATITIS TRACK - Managing Severe and Refractory Atopic Dermatitis
G.03 (HICC)
13:30 - 13:35
Welcoming Remarks
13:35 - 13:50
15-1PG:
Atopic Dermatitis in Food Allergy |
13:50 - 14:05
15-2PG:
Role of Immunomodulators in Treatment |
14:05 - 14:20
15-3PG:
Complications that Require Intervention |
14:20 - 15:00
Discussion
|
Postgraduate Course 16: URTICARIA & ANGIOEDEMA TRACK - Understanding and Managing Acute and Chronic Urticaria
G.04 (HICC)
13:30 - 13:35
Welcoming Remarks
13:35 - 13:50
13:50 - 14:05
16-2PG:
Diagnostic Approach and Treatment |
14:05 - 14:20
14:20 - 15:00
Discussion
|
Postgraduate Course 17: FOOD ALLERGY TRACK - Recent Advances in Diagnosis and Oral Food Challenge Test
G.05 (HICC)
13:30 - 13:35
Welcoming Remarks
13:35 - 13:50
17-1PG:
Component Reseolved Diagnostic (CRD) |
13:50 - 14:05
17-2PG:
Basophil Activation Markers |
14:05 - 14:20
17-3PG:
Oral Food Challenge |
14:20 - 15:00
Discussion
|
Postgraduate Course 18: IMMUNOTHERAPY TRACK - Managing Adverse Reactions to Immunotherapy
G.06 (HICC)
13:30 - 13:35
Welcoming Remarks
13:35 - 13:50
13:50 - 14:05
18-2PG:
Avoiding Adverse Reactions |
14:05 - 14:20
18-3PG:
Managing Adverse Reactions |
14:20 - 15:00
Discussion
|
15:30 - 17:00
Postgraduate Course 19: ALLERGY, ASTHMA AND SLEEP DISORDERS TRACK - Sleep Workshop
G.01 (HICC)
15:30 - 15:35
Welcoming Remarks
15:35 - 15:50
15:50 - 16:05
19-2PG:
Evaluating a Patient with Sleep Apnea |
16:05 - 16:20
16:20 - 17:00
Discussion
|
Postgraduate Course 20: INHALATION DEVICES TRACK
G.02 (HICC)
15:30 - 15:35
Welcoming Remarks
15:35 - 15:50
20-1PG:
Inhalation Devices in the US |
15:50 - 16:05
20-2PG:
Inhalation Devices in India |
16:05 - 16:20
20-3PG:
Inhalation Devices in the Far East |
16:20 - 17:00
Discussion
|
Postgraduate Course 21: ATOPIC DERMATITIS TRACK - Understanding and Managing Atopic Dermatitis
G.03 (HICC)
15:30 - 15:35
Welcoming Remarks
15:35 - 15:50
21-1PG:
Overview of Pathogenesis |
15:50 - 16:05
21-2PG:
Diagnosis and Treatment |
16:05 - 16:20
21-3PG:
Practical Issues in Skin Care |
16:20 - 17:00
Discussion
|
Postgraduate Course 22: URTICARIA & ANGIOEDEMA TRACK - Diagnosis and Treatment of Hereditary Angioedema (HAE)
G.04 (HICC)
15:30 - 15:35
Welcoming Remarks
15:35 - 15:50
22-1PG:
Definition and Mechanisms of HAE |
15:50 - 16:05
16:05 - 16:20
22-3PG:
Acute and Prophylactic Management |
16:20 - 17:00
Discussion
|
Postgraduate Course 23: FOOD ALLERGY TRACK - Practical Management of Food Allergy and Oral Desensitization
G.05 (HICC)
15:30 - 15:35
Welcoming Remarks
15:35 - 15:50
23-1PG:
Regional Perspectives |
15:50 - 16:05
23-2PG:
Practical Management of Food Allergy |
16:05 - 16:20
23-3PG:
Oral Immunotherapy |
16:20 - 17:00
Discussion
|
Postgraduate Course 24: IMMUNOTHERAPY TRACK - Hands-On Demonstration of Allergen Preparation and Use
G.06 (HICC)
15:30 - 15:35
Welcoming Remarks
15:35 - 15:50
15:50 - 16:05
16:05 - 16:20
16:20 - 17:00
Discussion
|
Friday, 7 December 2012
08:00 - 09:30
Plenary Session 1: The Origins of Allergy
Hall 3 (HICC)
08:00 - 08:05
Welcoming Remarks
08:05 - 08:30
08:30 - 08:55
08:55 - 09:20
09:20 - 09:30
Discussion
|
10:00 - 11:45
Symposium 1: WAO-APAPARI Session: Food Allergy and Gastrointestinal (GI) Tract
Hall 3 (HICC)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:25
10:25 - 10:45
1-2SY:
The Role of Dietary Nutrients in the Predisposition and Modulation of the Allergic Response |
10:45 - 11:05
11:05 - 11:25
1-4SY:
Component Analysis for Diagnosis |
11:25 - 11:45
Discussion
|
10:00 - 11:30
Symposium 2: Severe Upper Airways Disease
Hall 1 and 2 (HICC)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:25
10:25 - 10:45
10:45 - 11:05
2-3SY:
Severe Rhinosinusitis |
11:05 - 11:30
Discussion
|
Symposium 3: EAACI-WAO World Allergy and Asthma Congress – Milan 2013: Immune Effector Mechanisms and Immune Tolerance in Allergic Disease
Hall 5 and 6 (HICC)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:25
10:25 - 10:45
10:45 - 11:05
11:05 - 11:30
Discussion
|
11:45 - 12:15
Keynote Lecture 1: The Role of Translational Research in Addressing Health Disparities
Hall 3 (HICC)
12:15 - 12:45
Keynote Lecture 2: European Respiratory Roadmap
Hall 3 (HICC)
12:45 - 14:15
Plenary Session 2: Food Allergy
Hall 3 (HICC)
12:45 - 12:50
Welcoming Remarks
12:50 - 13:15
13:15 - 13:40
13:40 - 14:05
14:05 - 14:15
Discussion
|
14:45 - 16:50
Symposium 6: The Environment and Occupational Allergies
Hall 5 and 6 (HICC)
14:45 - 14:50
Welcoming Remarks
14:50 - 15:10
6-1SY:
Occupational Airway Diseases |
15:10 - 15:30
15:30 - 15:50
6-3SY:
Indoor and Outdoor Air Pollutants |
15:50 - 16:10
6-4SY:
Biodiversity |
16:10 - 16:30
6-5SY:
Climate Change and Allergy |
16:30 - 16:50
Discussion
|
14:45 - 16:30
Symposium 4: Life Altering Allergic Disorders
Hall 3 (HICC)
14:45 - 14:50
Welcoming Remarks
14:50 - 15:10
4-1SY:
Hereditary Angioedema |
15:10 - 15:30
4-2SY:
Eosinophilic Esophagitis |
15:30 - 15:50
4-3SY:
Mastocytosis |
15:50 - 16:10
16:10 - 16:30
Discussion
|
Symposium 5: Severe Ocular Allergies
Hall 1 and 2 (HICC)
14:45 - 14:50
Welcoming Remarks
14:50 - 15:10
5-1SY:
Pathophysiology of Ocular Allergies |
15:10 - 15:30
15:30 - 15:50
15:50 - 16:10
16:10 - 16:30
Discussion
|
16:30 - 17:30
Poster Session 1-1: Asthma Diagnosis and Treatment 1
Hall 4 (HICC)
1001
1002
1003
1004
1005
1006
1007
1008
1009
1010
1011
1012
1013
1014
1015
|
Poster Session 1-2: Asthma Diagnosis and Treatment 2
Hall 4 (HICC)
1016
1017
1018
1019
1021
1022
1023
1024
1024:
Prevalence of Depression Among Asthma Patients & Effects of Asthma Control On Severity of Depression |
1025
1026
1027
1028
1029
|
Poster Session 1-3: Environmental and Occupational Respiratory Diseases 1
Hall 4 (HICC)
1030
1031
1032
1033
1034
1035
1035:
Isolation and Purification of Major Allergenic Protein of Moth and Rice Weevil Insect Extracts |
1036
1037
|
Poster Session 1-4: Environmental and Occupational Respiratory Diseases 2
Hall 4 (HICC)
1038
1039
1040
1041
1042
1043
1044
1045
1046
1047
1048
1049
|
Poster Session 1-5: Environmental and Occupational Respiratory Diseases 3
Hall 4 (HICC)
1050
1051
1052
1053
1054
1055
1055:
CD23, Th1/Th2 Cytokines in Children with Bronchial Asthma, Bronchiolitis and Bronchial Pneumonia |
1056
1057
1058
1059
1060
1061
1062
1063
|
Poster Session 1-6: Mechanisms of Asthma and Allergic Disease 1
Hall 4 (HICC)
1064
1065
1065:
Association Between Level of Serum IL 31 and IL 33 and Pruritus in Malaysian Allergic Patients |
1066
1068
1069
1070
1071
1072
1073
1074
1075
1076
1077
1077:
Differential Expression and Roles of MMP-2, MMP-9, MMP-13, TIMP-1, and TIMP-2 in Allergic Rhinitis |
1078
|
Poster Session 1-7: Mechanisms of Asthma and Allergic Disease 2
Hall 4 (HICC)
1079
1080
1081
1082
1083
1084
1085
1085:
Safety and Tolerability of Escalating Doses of House Dust Mite Peptide Antigen Desensitisation |
1086
1087
1088
1089
1090
1090:
Eosinophils Enhance Airway Smooth Muscle Cell Proliferation Via the Release of Cystl Leukotrines |
1091
1092
1093
1094
|
Saturday, 8 December 2012
08:00 - 09:30
Plenary Session 3: Severe Asthma
Hall 3 (HICC)
08:00 - 08:05
Welcoming Remarks
08:05 - 08:30
3-1PS:
Severe Asthma Phenotypes in Adults |
08:30 - 08:55
08:55 - 09:20
09:20 - 09:30
Discussion
|
10:00 - 12:00
Symposium 8: Confounders of Asthma Treatment
Hall 2 (HICC)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:25
8-1SY:
Vocal Cord Dysfunction (VCD) |
10:25 - 10:45
10:45 - 11:05
8-3SY:
Rhinosinusitis / Nasal Polyps |
11:05 - 11:25
11:25 - 11:45
11:45 - 12:00
Discussion
|
10:00 - 11:45
Company Sponsored Symposium 1: Sanofi: Managing Airways Diseases in 2012
Hall 1 (HICC)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:35
10:35 - 11:05
11:05 - 11:35
1-3CSS:
From the Mediators to the Patient |
11:35 - 11:45
Panel Discussion
|
Symposium 9: Severe Adverse Reactions to Drugs
Hall 5 and 6 (HICC)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:25
10:25 - 10:45
10:45 - 11:05
11:05 - 11:25
11:25 - 11:45
Discussion
|
10:00 - 11:30
Symposium 7: Childhood Asthma
Hall 3 (HICC)
10:00 - 10:05
Welcoming Remarks
10:05 - 10:25
10:25 - 10:45
10:45 - 11:05
11:05 - 11:30
Discussion
|
10:00 - 10:30
Special Lecture 1: Bronchial Thermoplasty in Asthma
G.01 (HICC)
12:00 - 12:30
Keynote Lecture 3: A Holistic Approach to Severe and Complex Allergies
Hall 3 (HICC)
12:30 - 13:00
Keynote Lecture 4: Freddy Hargreave Memorial Lecture: Sputum Inflammometry in the Management of Severe Asthma
Hall 3 (HICC)
13:00 - 14:00
Poster Session 2-1: Allergic Diseases of the Skin and Drug Allergies 1
Hall 4 (HICC)
2001
2002
2002:
Association of Food and Drug Allergy with Anti-Tuberculosis Drug Related Hepatitis or Skin Reactions |
2003
2004
2005
2006
2007
2008
2009
2010
2010:
Intradermal Skin Testing with Cefazolin Regardless of the History of Hypersensitivity to Antibiotics |
2011
2012
2012:
Is There Association Between Duration of Seasonal Allergic Rhinitis and Oral Allergy Syndrome? |
2013
2013:
Longitudinal Analysis of Fecal Microbiota of Infants Followed-up for Eczema till 2 Years of Age |
2014
2015
2016
2017
2018
|
Poster Session 2-2: Allergic Diseases of the Skin and Drug Allergies 2
Hall 4 (HICC)
2019
2019:
Higher Doses for Heavy Hives |
2020
2021
2022
2023
2023:
Sulfamethoxazole / Trimethoprim Induced Leukocyte Count Decreased in 79–Old-Year Female Patient |
2024
2024:
Autoserum Therapy in Autologous Serum Skin Test Positive Patients of Chronic Spontaneous Urticaria |
2026
2027
2028
2029
2030
2030:
Validation of Cephalosporin Skin Test for Predicting Immediate Hypersensitivity: Interim Analysis |
2031
2032
2033
2035
2036
|
Poster Session 2-3: Food Allergy and Anaphylaxis 1
Hall 4 (HICC)
2037
2038
2038:
Insect and Sting Allergy |
2039
2040
2041
2042
2042:
High Rates of Egg Reactivity in Infants with Eczema Randomised to Receive Egg Under 6 Months of Age |
2043
2044
2045
2046
2047
2049
2051
|
Poster Session 2-4: Food Allergy and Anaphylaxis 2
Hall 4 (HICC)
2052
2053
2054
2054:
Easy-to-Use Severity Grading System for Treatment of Symptoms Induced by Oral Food Challenge |
2055
2056
2057
2058
2059
2059:
Mild Symptoms Induced by Oral Food Challenge Are Not Always Associated with Failed Challenge Results |
2060
2061
2062
2063
2064
2065
|
Poster Session 2-5: Immunotherapy 1
Hall 4 (HICC)
2066
2067
2068
2069
2070
2071
2072
2073
2074
2075
|
Poster Session 2-6: Immunotherapy 2
Hall 4 (HICC)
2076
2077
2078
2079
2080
2081
2082
2083
2084
|
Poster Session 2-7: Rhinitis, Sinusitis and Ocular Disease
Hall 4 (HICC)
2085
2086
2086:
Nox4 Mediates Hypoxia-Stimulated Myofibroblast Differentiation in Nasal Polyp-Derived Fibroblasts |
2087
2088
2089
2090
2091
2092
2093
2094
2095
2096
2097
2098
2099
2100
2102
2103
|
14:00 - 15:30
Plenary Session 4: Anaphylaxis
Hall 3 (HICC)
14:00 - 14:05
Welcoming Remarks
14:05 - 14:30
4-1PS:
Mechanisms of Anaphylaxis |
14:30 - 14:55
14:55 - 15:20
4-3PS:
Anaphylaxis, Asthma and Pregnancy |
15:20 - 15:30
Discussion
|
15:45 - 17:30
Company Sponsored Symposium 2: MSD: Asia Pacific Perspectives in Asthma Management
Hall 1 (HICC)
15:45 - 15:50
Welcoming Remarks
15:50 - 16:15
16:15 - 16:40
16:40 - 17:05
17:05 - 17:30
Panel Discussion
|
Symposium 10: Allergy Diagnostics: Current and Future Perspectives
Hall 3 (HICC)
15:45 - 15:50
Welcoming Remarks
15:50 - 16:10
10-1SY:
In-Vivo and In-Vitro Diagnostic Tests |
16:10 - 16:30
16:30 - 16:50
16:50 - 17:10
10-4SY:
Molecular Allergology |
17:10 - 17:30
Discussion
|
Symposium 11: Indian College of Allergy, Asthma and Applied Immunology (ICAAI): Highlights of Airway Diseases in India
Hall 2 (HICC)
15:45 - 15:50
Welcoming Remarks
15:50 - 16:10
16:10 - 16:30
11-2SY:
Genetics of Asthma in India |
16:30 - 16:50
16:50 - 17:10
11-4SY:
Pediatric Asthma in India |
17:10 - 17:30
Discussion
|
Symposium 12: Precision Treatments in Allergic Disorders
Hall 5 and 6 (HICC)
15:45 - 15:50
Welcoming Remarks
15:50 - 16:10
12-1SY:
Update on Anti-IgE |
16:10 - 16:30
12-2SY:
Update on Anti-Cytokines |
16:30 - 16:50
16:50 - 17:10
12-4SY:
New Imaging Approaches to Asthma |
17:10 - 17:30
Discussion
|
Sunday, 9 December 2012
07:45 - 10:30
1965: Session 1
G.03 (HICC)
07:45 - 08:00
Welcoming Remarks
08:00 - 08:30
08:30 - 09:00
09:00 - 09:30
09:30 - 10:00
10:00 - 10:30
|
08:00 - 09:30
Plenary Session 5: Skin Allergies
Hall 3 (HICC)
08:00 - 08:05
Welcoming Remarks
08:05 - 08:30
5-1PS:
Update on Chronic Urticaria |
08:30 - 08:55
08:55 - 09:20
09:20 - 09:30
Discussion
|
08:30 - 10:00
General Practitioner Program 1: Objective Assessment of Upper Airway Diseases: Hands-on Rhinolaryngoscopy and Nasal Challenge Tests
G.01 (HICC)
08:30 - 08:35
Welcoming Remarks
08:35 - 08:55
08:55 - 09:15
1-2GP:
Imaging |
09:15 - 09:35
1-3GP:
Nasal Endoscopy: Practical Aspects |
09:35 - 10:00
Discussion
|
10:30 - 11:30
Poster Session 3-1: Allied Health
Hall 4 (HICC)
3001
3002
3003
3004
3005
3006
3007
3008
3009
|
Poster Session 3-2: Basic and Clinical Immunology 1
Hall 4 (HICC)
3010
3011
3011:
Evaluation of Selected Parameters of Cellular Immunity At Diagnosis in Children with Osteosarcoma |
3012
3013
3014
3015
3016
|
Poster Session 3-3: Basic and Clinical Immunology 2
Hall 4 (HICC)
3017
3018
3019
3019:
Gamma Interferon Release Assay for Diagnosis of Latent Tuberculosis- Comparison with TB Skin Test |
3020
3021
3022
3023
3024
3025
3026
3026:
Kartagener's Syndrome |
3027
3028
3028:
Interaction of DNA Methylation and Genetic Variants of IL13 Is Associated with FEV1/FVC and Bhr |
3029
3030
3031
3032
3032:
18FDG-PET/CT Findings (suv-max) are Correlated with Survival in Stage-4 Squamous cell carcinoma |
3033
3034
3035
3035:
The Imbalance of Parameters of Immune System in Children with Nosocomial Pneumonia and Dysbiosis |
3036
|
Poster Session 3-4: Health Outcomes, Education, Healthcare Delivery and Quality 1
Hall 4 (HICC)
3037
3038
3039
3040
3040:
Occurrence and Effects of Nasal Polyps in Patients with Bronchial Asthma and/or Allergic Rhinitis |
3041
3042
3042:
Quality of Life in Children with Atopic Dermatitis and Its Relationship with Disease Severity |
3043
3044
3045
3046
3047
3048
3049
3050
|
Poster Session 3-5: Health Outcomes, Education, Healthcare Delivery and Quality 2
Hall 4 (HICC)
3051
3052
3053
3053:
Is It Necessary to Re-Evaluate the Airway Hyperresponsiveness While in the Treatment of Mild Asthma? |
3054
3055
3056
3057
3058
3059
3059:
Relation Between Body Mass Index and Control of Bronchial Asthma Among Egyptian Adults with Asthma |
3060
3061
3061:
Usage of Electronic Medical Record in A Tertiary Care Institute: A Questionnaire Based Study |
3062
3063
|
11:00 - 12:30
General Practitioner Program 2: Spirometry and Inhalation Devices
G.01 (HICC)
11:00 - 11:05
Welcoming Remarks
11:05 - 11:25
2-1GP:
Spirometry |
11:25 - 11:45
2-2GP:
Inhalation Devices |
11:45 - 12:05
2-3GP:
Inhalation Devices in India |
12:05 - 12:30
Discussion
|
11:30 - 13:15
Symposium 15: Small Airways Disease
Hall 5 and 6 (HICC)
11:30 - 11:35
Welcoming Remarks
11:35 - 11:55
15-1SY:
Particle Deposition and Pharmacotherapy |
11:55 - 12:15
15-2SY:
Pathophysiology of the Small Airways |
12:15 - 12:35
12:35 - 12:55
15-4SY:
Optimal Assessment of asthma Control in Clinical Practice: Is there a Role for Biomarkers? |
12:55 - 13:15
Discussion
|
11:30 - 13:00
Company Sponsored Symposium 3: MSD: Upper Airway Inflammatory Disease: Opportunity & Challenges
Hall 1 (HICC)
11:30 - 11:35
Welcoming Remarks
11:35 - 12:00
12:00 - 12:25
12:25 - 12:50
12:50 - 13:00
Panel Discussion
|
Symposium 13: HIGHLIGHT ON IMMUNOTHERAPY 1
Hall 3 (HICC)
11:30 - 11:35
Welcoming Remarks
11:35 - 11:55
13-1SY:
Mechanisms of Immunotherapy |
11:55 - 12:15
13-2SY:
Sublingual Immunotherapy |
12:15 - 12:35
12:35 - 13:00
Discussion
|
Symposium 14: Disease Prevention in the New Millennium: Allergy in the Context of Other NCDs
Hall 2 (HICC)
11:30 - 11:35
Welcoming Remarks
11:35 - 11:55
11:55 - 12:15
12:15 - 12:35
12:35 - 13:00
Discussion
|
13:00 - 14:30
1966: Session 3
G.03 (HICC)
13:00 - 13:30
13:30 - 14:00
14:00 - 14:30
|
13:30 - 15:30
General Practitioner Program 3: Improving Patient’s Asthma Control and Quality of Life
G.01 (HICC)
13:30 - 13:35
Welcoming Remarks
13:35 - 13:55
3-1GP:
Compliance and Treatment Adherence |
13:55 - 14:15
14:15 - 14:35
3-3GP:
Differentiating Asthma from COPD |
14:35 - 14:55
14:55 - 15:30
Discussion
|
13:30 - 14:00
Keynote Lecture 5: Pharmacogenetics
Hall 3 (HICC)
15:00 - 16:45
Symposium 16: HIGHLIGHT ON IMMUNOTHERAPY 2
Hall 3 (HICC)
15:00 - 15:05
Welcoming Remarks
15:05 - 15:25
16-1SY:
Immunomodulators - Anti-IgE mAb |
15:25 - 15:45
15:45 - 16:05
16:05 - 16:25
16-4SY:
Insect Immunotherapy |
16:25 - 16:45
Discussion
|
Symposium 17: Microbiome
Hall 2 (HICC)
15:00 - 15:05
Welcoming Remarks
15:05 - 15:25
15:25 - 15:45
15:45 - 16:05
16:05 - 16:25
16:25 - 16:45
Discussion
|
Symposium 18: Chronic Rhinosinusitis
Hall 5 and 6 (HICC)
15:00 - 15:05
Welcoming Remarks
15:05 - 15:25
15:25 - 15:45
15:45 - 16:05
16:05 - 16:25
18-4SY:
Difficult Cases of CRS |
16:25 - 16:45
Discussion
|
15:00 - 16:15
1967: Workshop A
G.03 (HICC)
15:00 - 16:15
|
1968: Workshop B
G.06 (HICC)
15:00 - 15:35
15:35 - 16:10
|
16:45 - 17:50
Symposium 19: HIGHLIGHT ON IMMUNOTHERAPY 3
Hall 3 (HICC)
16:45 - 16:50
Welcoming Remarks
16:50 - 17:10
17:10 - 17:30
19-2SY:
Prevention |
17:30 - 17:50
Discussion
|